| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.19 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.031 | 0.6 |